MOESM5 of Residual tissue repositories as a resource for population-based cancer proteomic studies

Additional file 5: Table S5.  Identified peptides, proteins, and phosphopeptides

MOESM2 of Residual tissue repositories as a resource for population-based cancer proteomic studies

Additional file 2: Table S2.  TMT labeling scheme for phosphoproteomics

MOESM1 of Residual tissue repositories as a resource for population-based cancer proteomic studies

Additional file 1: Table S1.  TMT labeling scheme for expression proteomics

MOESM7 of Residual tissue repositories as a resource for population-based cancer proteomic studies

Additional file 7: Table S6. Significantly affected GO terms

MOESM6 of Residual tissue repositories as a resource for population-based cancer proteomic studies

Additional file 6.  Supplementary figures

MOESM4 of Residual tissue repositories as a resource for population-based cancer proteomic studies

Additional file 4: Table S4.  Table of specimen age and RTR

MOESM4 of Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics

Additional file 4: Table S2. Details of the PRISM-SRM assays developed for the SPOP peptides in the mutation and non-mutation regions